119th Congress
S. 526
Pharmacy Benefit Manager Transparency Act of 2025
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Chuck Grassley(R-IA)
- Introduced
- Feb 11, 2025
- Policy area
- Health
- Committees
- Senate Committee on Commerce, Science, and Transportation
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (14)
Original cosponsors (11)
- Cindy Hyde-Smith (R-MS)
- Jeanne Shaheen (D-NH)
- Jerry Moran (R-KS)
- Joni Ernst (R-IA)
- Maria Cantwell (D-WA)
- Martin Heinrich (D-NM)
- Mike Rounds (R-SD)
- Peter Welch (D-VT)
- Roger Marshall (R-KS)
- Shelley Moore Capito (R-WV)
- Thom Tillis (R-NC)
Added later (3)
- John Boozman (R-AR) · Feb 18, 2025
- Ruben Gallego (D-AZ) · Sep 15, 2025
- Raphael G. Warnock (D-GA) · Dec 18, 2025
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Latest action(Feb 11, 2025): Read twice and referred to the Committee on Commerce, Science, and Transportation.
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 11, 2025 · Senate
Read twice and referred to the Committee on Commerce, Science, and Transportation. - Feb 11, 2025
Introduced in Senate